Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-12-27 Disposition | 2023-12-27 5:39 pm | N/A 2026-07-20 | POINT Biopharma Global Inc. | PNT | JENSEN JESSICA D. EVP Clinical Development | 949,925 | $0 | 0 (Direct) | View |
| 2023-03-28 Option Award | 2023-03-30 8:08 pm | N/A 2029-03-28 | POINT Biopharma Global Inc. | PNT | JENSEN JESSICA D. EVP Clinical Development | 136,055 | $0 | 136,055 (Direct) | View |
| 2022-04-01 Option Award | 2022-04-05 10:48 am | N/A 2028-04-01 | POINT Biopharma Global Inc. | PNT | JENSEN JESSICA D. EVP Clinical Development | 13,766 | $0 | 13,766 (Direct) | View |
| 2022-03-29 Option Award | 2022-03-31 5:01 pm | N/A 2028-03-29 | POINT Biopharma Global Inc. | PNT | JENSEN JESSICA D. EVP Clinical Development | 213,301 | $0 | 213,301 (Direct) | View |
| 2021-07-06 Option Award | 2021-07-08 4:37 pm | N/A 2027-07-06 | POINT Biopharma Global Inc. | PNT | JENSEN JESSICA D. EVP Clinical Development | 461,250 | $0 | 461,250 (Direct) | View |
| 2021-06-30 Option Award | 2021-06-30 9:30 pm | N/A 2026-07-20 | POINT Biopharma Global Inc. | PNT | JENSEN JESSICA D. EVP Clinical Development | 125,553 | $0 | 125,553 (Direct) | View |